Endovascular Engineering, Inc. develops the Hēlo™ PE Thrombectomy System, which utilizes a self-expanding funnel design and dual-action technology to effectively engage and remove clots in patients with venous thromboembolism. This system addresses the challenges of navigating complex anatomies while minimizing hemodynamic impact through its small profile and large bore performance.
Funding
$23M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CSVFounders
Product
Problem
Current methods for removing blood clots in patients with venous thromboembolism can be challenging due to the complex anatomy of blood vessels. Large-bore catheters, while effective at clot removal, can increase the risk of hemodynamic instability, while smaller catheters may struggle to effectively engage and remove large clots.
Solution
Endovascular Engineering's Hēlo™ PE Thrombectomy System offers a solution for pulmonary embolism treatment by combining the benefits of both large and small-bore thrombectomy systems. The system utilizes a self-expanding funnel design to ensure a wide distal opening for effective clot engagement, similar to large-bore catheters. Its dual-action technology employs high-speed agitation and simultaneous physician-controlled aspiration to break down and remove clots, all within a small profile system designed for easy navigation through complex anatomies. This approach aims to minimize hemodynamic impact while maximizing clot removal efficiency in a single pass.
Target Audience
The primary target audience includes interventional cardiologists, vascular surgeons, and other medical professionals specializing in the treatment of venous thromboembolism and pulmonary embolism.
Features
- Self-expanding funnel design for wide clot engagement.
- Dual-action technology combining high-speed agitation and aspiration.
- Small catheter profile for navigation in complex anatomies.
- Integrated handle for enhanced control and maneuverability.
- Single-pass clot removal capability.